Economic Evaluation of Cancer Drugs av Iftekhar Khan, Ralph Crott, Zahid (Haemato-Oncology Welwyn Garden City UK) Bashir

1449,-

Kjøp

<P>Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, <B>Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data</B> is the first unified text that specifically addresses the economic evaluation of cancer drugs. </P><P></P><P>The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trial